[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366622-105":59,"doc-detail-366622-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comprehensive-pan-cancer-analysis-of-trnt1-as-a-potential-biomarker-for-breast-cancer","Comprehensive Pan-Cancer Analysis of TRNT1 as a Potential Biomarker for Breast Cancer","","TRNT1, an RNA nucleotide transferase, is proposed as a cancer-related regulator whose clinical value remains unclear. A pan-cancer bioinformatics workflow combined GEPIA2, cBioPortal, TIMER2, Metascape, and UALCAN with experimental validation to evaluate gene expression, prognosis, genomic alterations, immune infiltration, and pathway enrichment. TRNT1 shows high expression across most cancers and correlates with patient outcomes, particularly in breast cancer. Promoter methylation and genomic changes may drive abnormal expression, with functional enrichment pointing to protein processing and RNA metabolism, while experimental evidence supports TRNT1 overexpression and roles in proliferation and apoptosis via the P53 pathway.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-pan-cancer-analysis-of-trnt1-as-a-potential-biomarker-for-breast-cancer/366622/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-pan-cancer-analysis-of-trnt1-as-a-potential-biomarker-for-breast-cancer/366622.png","ImageObject",300,407,{"name":92,"@type":93},"Ben ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study on TRNT1 in cancer?","Question",{"text":112,"@type":113},"To determine the potential significance of TRNT1 in cancer, with a focus on breast cancer progression and prognosis, by integrating pan-cancer bioinformatics analysis with experimental validation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which analyses were used to evaluate TRNT1 across cancers?",{"text":117,"@type":113},"The study used multiple online bioinformatics tools (GEPIA2, cBioPortal, TIMER2, Metascape, and UALCAN) to assess gene expression, prognosis, genomic alterations, immune infiltration, and functional enrichment, followed by in vitro experiments for breast cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"How does TRNT1 relate to breast cancer and patient prognosis?",{"text":121,"@type":113},"TRNT1 is reported as highly expressed in most cancers and significantly associated with prognosis, with evidence indicating TRNT1 is overexpressed in breast cancer and may contribute to tumor proliferation and apoptosis through the P53 pathway.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366622,1790210697,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Journal of Cellular and Molecular Medicine   \n ORIGINAL ARTICLE  OPEN ACCESS   \nComprehensive Pan-Cancer Analysis of TRNT1 asa Potential Biomarker for Breast Cancer  \nXinwei Li1 | Yue Meng2,3 | Bing Gu2   \n1Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China | 2Laboratory Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical  \nUniversity, Guangzhou, China | 3Guangdong Provincial Clinical Research Center for Laboratory Medicine, Guangzhou, China Correspondence: Yue Meng ([mengyue@gdph.org.cn](mengyue@gdph.org.cn)) | Bing Gu ([gubing@gdph.org.cn](gubing@gdph.org.cn))  \nReceived: 5 December 2024 | Revised: 20 August 2025 | Accepted: 8 September 2025  \nFunding: This research was supported by the Research Foundation for Advanced Talents of Guangdong Provincial People's Hospital (KY012023289), Natural Science Foundation of Guangdong Province, China (Grant 2025A1515010446), the National Natural Science Foundation of China (82003149) and Guangdong Provincial Clinical Research Center for Laboratory Medicine (2023B110008) .  \nKeywords: biomarker | breast cancer | prognosis | TCGA | TRNT1  \nABSTRACT  \nTRNT1, an RNA nucleotide transferase, plays a critical role in cellular processes and may be involved in cancer. However, its role in cancer has not been fully explored. This study aims to explore the potential significance of TRNT1 in cancer, particularly in breast cancer (BC) progression and prognosis. A pan-cancer analysis of TRNT1 was conducted using various online bioinformatics tools, including GEPIA2, cBioPortal, TIMER2, Metascape, and UALCAN, combined with experimental validation. The analysis encompassed gene expression, prognosis, genomic alterations, immune infiltration, and functional enrichment. Additionally, in vitro experiments were performed to further investigate TRNT1's role in BC. TRNT1 is highly expressed inmost cancers, with significant correlation to prognosis, especially in BC. Promoter methylation and genomic alterations may contribute to its abnormal expression. Furthermore, functional enrichment analysis revealed that TRNT1-associated genes are primarily involved in protein processing and RNA metabolism. Our study also represents the first evidence that TRNT1 is overexpressed in BC, participates in tumour proliferation, and may regulate apoptosis through the P53 pathway. This initial pan-cancer study provides a relatively comprehensive understanding of the oncogenic role of TRNT1 across various cancers and highlights its potential as a biomarker for BC.  \n\n| Abbreviations: BC, breast cancer; BLCA, bladder urothelial carcinoma; cBioPortal, cancer genomics portal; CHOL, cholangiocarcinoma; COAD, colon adenocarcinoma; CPTAC, clinical proteomic tumour analysis consortium; ESCA, oesophageal carcinoma; ESCC, oesophageal squamous cell carcinoma; GEPIA2, gene expression profiling interactive analysis (version 2); GO, gene ontology; HNSC, head and neck squamous cell carcinoma; HPA, human protein atlas; IHC, immunohistochemical; KEGG, Kyoto encyclopedia of genes and genomes; KICH, kidney chromophobe; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LIHC, liver hepatocellular carcinoma; LUAD, lung adenocarcinoma; OC, ovarian cancer; OS, overall survival; PAAD, pancreatic adenocarcinoma; PCPG, pheochromocytoma and paraganglioma; PRAD, prostate adenocarcinoma; RCC, renal cell carcinoma; READ, rectum adenocarcinoma; SARC, sarcoma; STAD, stomach adenocarcinoma; STRING, search tool for the retrieval of interacting genes/proteins; TCGA, the Cancer Genome Atlas; THCA, thyroid carcinoma; TIME, tumour immune microenvironment; TIMER2.0, tumour immune estimation resource (version 2.0); TISIDB, tumour immune single-cell expression database; TLS, tertiary lymphoid structures; TMAs, tissue microarrays; UALCAN, University of Alabama at Birmingh","cbCaiiI7DscIjiIv","https://ap.wps.com/l/cbCaiiI7DscIjiIv","pdf",8394806,15,"English","# Introduction\n# Abstract\n# Materials and Methods\n## Bioinformatics Analysis\n## Experimental Validation","[{\"question\":\"What is the main goal of the study on TRNT1 in cancer?\",\"answer\":\"To determine the potential significance of TRNT1 in cancer, with a focus on breast cancer progression and prognosis, by integrating pan-cancer bioinformatics analysis with experimental validation.\"},{\"question\":\"Which analyses were used to evaluate TRNT1 across cancers?\",\"answer\":\"The study used multiple online bioinformatics tools (GEPIA2, cBioPortal, TIMER2, Metascape, and UALCAN) to assess gene expression, prognosis, genomic alterations, immune infiltration, and functional enrichment, followed by in vitro experiments for breast cancer.\"},{\"question\":\"How does TRNT1 relate to breast cancer and patient prognosis?\",\"answer\":\"TRNT1 is reported as highly expressed in most cancers and significantly associated with prognosis, with evidence indicating TRNT1 is overexpressed in breast cancer and may contribute to tumor proliferation and apoptosis through the P53 pathway.\"}]","Comprehensive Pan-Cancer Analysis of TRNT1 as a Potential Biomarker for Breast Cancer | PDF",1790166464,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce72162167a4f34c0b4f9c9bf99f7706.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7257ef4b67d5deecd91319ed7abcd5a2.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95c9511d77a4ff6e5192702bbcad0805.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aa47ab943024aa396146dcbadb9a7ee3.webp",980,1287]